Université d'Auvergne Clermont1 | CNRS


New-Onset Left Bundle Branch Block Induced by Transcutaneous Aortic Valve Implantation.

TitleNew-Onset Left Bundle Branch Block Induced by Transcutaneous Aortic Valve Implantation.
Publication TypeJournal Article
Year of Publication2016
AuthorsMassoullié, G., P. Bordachar, K. A. Ellenbogen, G. Souteyrand, F. Jean, N. Combaret, C. Vorilhon, G. Clerfond, M. Farhat, P. Ritter, B. Citron, J. - R. Lusson, P. Motreff, S. Ploux, and R. Eschalier
JournalThe American journal of cardiology
Date Published2016 Mar 1

New-onset left bundle branch block (LBBB) is a specific concern of transcutaneous aortic valve implantation (TAVI) given its estimated incidence ranging from 5% to 65%. This high rate of occurrence is dependent on the type of device used (size and shape), implantation methods, and patient co-morbidities. The appearance of an LBBB after TAVI reflects a very proximal lesion of the left bundle branch as it exits the bundle of His. At times transient, its persistence can lead to permanent pacemaker implantation in 15% to 20% of cases, most often for high-degree atrioventricular block. The management of LBBB after TAVI is currently not defined by international societies resulting in individual centers developing their own management strategy. The potential consequences of LBBB are dysrhythmias (atrioventricular block, syncope, and sudden death) and functional (heart failure) complications. Prompt postprocedural recognition and management (permanent pacemaker implantation) of patients prevents the occurrence of potential complications and may constitute the preferred approach in this frail and elderly population despite additional costs and complications of cardiac pacing. Moreover, the expansion of future indications for TAVI necessitates better identification of the predictive factors for the development of LBBB. Indeed, long-term right ventricular pacing may potentially increase the risk of developing heart failure in this population. In conclusion, it is thus imperative to not only develop new aortic prostheses with a less-deleterious impact on the conduction system but also to prescribe appropriate pacing modes in this frail population.

Alternate JournalAm. J. Cardiol.